These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 29874584)

  • 21. Protective role of SIRT5 against motor deficit and dopaminergic degeneration in MPTP-induced mice model of Parkinson's disease.
    Liu L; Peritore C; Ginsberg J; Shih J; Arun S; Donmez G
    Behav Brain Res; 2015 Mar; 281():215-21. PubMed ID: 25541039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.
    Mazzulli JR; Zunke F; Tsunemi T; Toker NJ; Jeon S; Burbulla LF; Patnaik S; Sidransky E; Marugan JJ; Sue CM; Krainc D
    J Neurosci; 2016 Jul; 36(29):7693-706. PubMed ID: 27445146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells.
    Ratajczak J; Joffraud M; Trammell SA; Ras R; Canela N; Boutant M; Kulkarni SS; Rodrigues M; Redpath P; Migaud ME; Auwerx J; Yanes O; Brenner C; Cantó C
    Nat Commun; 2016 Oct; 7():13103. PubMed ID: 27725675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of the nicotinamide riboside kinase NAD
    Doig CL; Zielinska AE; Fletcher RS; Oakey LA; Elhassan YS; Garten A; Cartwright D; Heising S; Alsheri A; Watson DG; Prehn C; Adamski J; Tennant DA; Lavery GG
    Skelet Muscle; 2020 Feb; 10(1):5. PubMed ID: 32075690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decoding Parkinson's disease - iPSC-derived models in the OMICs era.
    Krach F; Bogiongko ME; Winner B
    Mol Cell Neurosci; 2020 Jul; 106():103501. PubMed ID: 32439399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling Parkinson's Disease Using Patient-specific Induced Pluripotent Stem Cells.
    Li H; Jiang H; Zhang B; Feng J
    J Parkinsons Dis; 2018; 8(4):479-493. PubMed ID: 30149462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3.
    Khan NA; Auranen M; Paetau I; Pirinen E; Euro L; Forsström S; Pasila L; Velagapudi V; Carroll CJ; Auwerx J; Suomalainen A
    EMBO Mol Med; 2014 Jun; 6(6):721-31. PubMed ID: 24711540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induced pluripotent stem cell (iPSC)-derived dopaminergic models of Parkinson's disease.
    Beevers JE; Caffrey TM; Wade-Martins R
    Biochem Soc Trans; 2013 Dec; 41(6):1503-8. PubMed ID: 24256244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ginseng protein protects against mitochondrial dysfunction and neurodegeneration by inducing mitochondrial unfolded protein response in Drosophila melanogaster PINK1 model of Parkinson's disease.
    Liu M; Yu S; Wang J; Qiao J; Liu Y; Wang S; Zhao Y
    J Ethnopharmacol; 2020 Jan; 247():112213. PubMed ID: 31562951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical Characteristics of iPSC-Derived Dopaminergic Neurons from N370S
    Grigor'eva EV; Kopytova AE; Yarkova ES; Pavlova SV; Sorogina DA; Malakhova AA; Malankhanova TB; Baydakova GV; Zakharova EY; Medvedev SP; Pchelina SN; Zakian SM
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901867
    [No Abstract]   [Full Text] [Related]  

  • 31. Parp mutations protect from mitochondrial toxicity in Alzheimer's disease.
    Yu Y; Fedele G; Celardo I; Loh SHY; Martins LM
    Cell Death Dis; 2021 Jun; 12(7):651. PubMed ID: 34172715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nicotinamide riboside and caffeine partially restore diminished NAD availability but not altered energy metabolism in Alzheimer's disease.
    Ryu WI; Shen M; Lee Y; Healy RA; Bormann MK; Cohen BM; Sonntag KC
    Aging Cell; 2022 Jul; 21(7):e13658. PubMed ID: 35730144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis.
    Schöndorf DC; Aureli M; McAllister FE; Hindley CJ; Mayer F; Schmid B; Sardi SP; Valsecchi M; Hoffmann S; Schwarz LK; Hedrich U; Berg D; Shihabuddin LS; Hu J; Pruszak J; Gygi SP; Sonnino S; Gasser T; Deleidi M
    Nat Commun; 2014 Jun; 5():4028. PubMed ID: 24905578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current perspective of mitochondrial biology in Parkinson's disease.
    Ammal Kaidery N; Thomas B
    Neurochem Int; 2018 Jul; 117():91-113. PubMed ID: 29550604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parkinson's disease-associated
    Mori A; Hatano T; Inoshita T; Shiba-Fukushima K; Koinuma T; Meng H; Kubo SI; Spratt S; Cui C; Yamashita C; Miki Y; Yamamoto K; Hirabayashi T; Murakami M; Takahashi Y; Shindou H; Nonaka T; Hasegawa M; Okuzumi A; Imai Y; Hattori N
    Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20689-20699. PubMed ID: 31548400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ER Lipid Defects in Neuropeptidergic Neurons Impair Sleep Patterns in Parkinson's Disease.
    Valadas JS; Esposito G; Vandekerkhove D; Miskiewicz K; Deaulmerie L; Raitano S; Seibler P; Klein C; Verstreken P
    Neuron; 2018 Jun; 98(6):1155-1169.e6. PubMed ID: 29887339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SLP-2 interacts with Parkin in mitochondria and prevents mitochondrial dysfunction in Parkin-deficient human iPSC-derived neurons and Drosophila.
    Zanon A; Kalvakuri S; Rakovic A; Foco L; Guida M; Schwienbacher C; Serafin A; Rudolph F; Trilck M; Grünewald A; Stanslowsky N; Wegner F; Giorgio V; Lavdas AA; Bodmer R; Pramstaller PP; Klein C; Hicks AA; Pichler I; Seibler P
    Hum Mol Genet; 2017 Jul; 26(13):2412-2425. PubMed ID: 28379402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The interplay of neuronal mitochondrial dynamics and bioenergetics: implications for Parkinson's disease.
    Van Laar VS; Berman SB
    Neurobiol Dis; 2013 Mar; 51():43-55. PubMed ID: 22668779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nicotinamide riboside attenuates alcohol induced liver injuries via activation of SirT1/PGC-1α/mitochondrial biosynthesis pathway.
    Wang S; Wan T; Ye M; Qiu Y; Pei L; Jiang R; Pang N; Huang Y; Liang B; Ling W; Lin X; Zhang Z; Yang L
    Redox Biol; 2018 Jul; 17():89-98. PubMed ID: 29679894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Azoramide protects iPSC-derived dopaminergic neurons with PLA2G6 D331Y mutation through restoring ER function and CREB signaling.
    Ke M; Chong CM; Zeng H; Huang M; Huang Z; Zhang K; Cen X; Lu JH; Yao X; Qin D; Su H
    Cell Death Dis; 2020 Feb; 11(2):130. PubMed ID: 32071291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.